Pramipexole

CHEMBL301265 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

211.3 g/mol

LogP

1.9

Phase

4

Used to treat the tremors, stiffness, and movement difficulties of Parkinson's disease by mimicking the action of dopamine, a brain chemical that is deficient in this condition. It is also approved for treating moderate to severe restless legs syndrome and has been studied for depression in bipolar disorder.

Peso Molecular

211,3300 g/mol

LogP

1,90

TPSA

79,20 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pain Management Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Epilepsy Migraine Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Multiple Sclerosis Chronic Kidney Disease Stroke Major Depressive Disorder Chronic Pain HIV/AIDS Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCN[C@H]1CCc2nc(N)sc2C1

InChI

InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1

Molecular Formula

C10H17N3S

HBD / HBA

2 / 4

Ligações Rotacionáveis

3

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Used to treat the tremors, stiffness, and movement difficulties of Parkinson's disease by mimicking the action of dopamine, a brain chemical that is deficient in this condition. It is also approved for treating moderate to severe restless legs syndrome and has been studied for depression in bipolar disorder.

Yes, Pramipexole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL301265. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 119570. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Pramipexole no PillFYI

Estrutura

Dados Rápidos

Fórmula: C10H17N3S
Sinônimos: 3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.